Coverage
Filings
Genmab A/S announced encouraging results from its Phase 1/2 RAINFOL-01 trial for rinatabart sesutecan (Rina-S), an investigational antibody-drug conjugate (ADC), in heavily pretreated patients with advanced endometrial cancer.
| 28 Nov 2007 |
| Articles of Association of Genmab A/S dated November 21, 2007 | 26 Nov 2007 |
| Capital Increase in Genmab as a Result of Employee Warrant Exercise | 21 Nov 2007 |
| Genmab and GlaxoSmithKline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program | 20 Nov 2007 |
| Report Pursuant to Section 28a of the Danish Securities Trading Act | 20 Nov 2007 |